Shares of Disc Medicine (IRON) are have fallen further to $43.99, marking a 39% decline.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRON:
- Disc Medicine drops 21% to $56.53 in afternoon plunge
- Iron Planet Inc. trading halted, volatility trading pause
- Disc Medicine: Differentiated EPP Therapy and Asymmetric FDA Catalyst Support Buy Rating
- FDA Calendar: These Are the Remaining Drug Approvals Anticipated This Month
- Disc Medicine: Bitopertin’s Accelerated Approval Path and FDA Timing Support Buy Rating and $118 Target